| New Jersey Veterans Memorial Home Menlo | |
| 132 Evergreen Rd, Edison, New Jersey 08818 | |
| (732) 452-4100 | |
| Name | New Jersey Veterans Memorial Home Menlo |
|---|---|
| Location | 132 Evergreen Rd, Edison, New Jersey |
| Certified By | Medicare |
| No. of Certified Beds | 328 |
| Occupancy Rate | 55.06% |
| Medicare ID (CCN) | 315459 |
| Legal Business Name | New Jersey Veterans Memorial Home Menlo Park |
| Ownership Type | Government - State |
| NPI Number | 1144557802 |
| Organization Name | NEW JERSEY VETERANS MEMORIAL HOME MENLO PARK |
| Address | 132 Evergreen Road,, Edison, NJ 08837 |
| Phone Number | 732-452-4100 |
News Archive
Children around the world are not moving enough to maintain healthy growth and development, according to a global report released today.
Oncologist and cancer care outcomes researcher Sharon H. Giordano, M.D., leads the new Department of Health Services Research at The University of Texas MD Anderson Cancer Center, a multidisciplinary area of research that examines the delivery, quality and costs of health care.
Half of the female population in the western world die of cardiovascular disease. Neither the women themselves, nor society at large recognizes this fact. Maybe because of this, research on women with acute coronary syndromes is scarce and thus we lack knowledge about the best way to properly treat women with an acute myocardial infarction.
A team led by Texas A&M University's College of Veterinary Medicine & Biomedical Sciences' researcher Dr. Stephen Safe has discovered a new pathway that may help suppress the development of glioblastoma tumors, one of the deadliest forms of cancer.
With the first U.S. implant of its new Activa SC neurostimulator for deep brain stimulation therapy, Medtronic, Inc. today announced the technology's commercial availability throughout the United States and Europe.
› Verified 7 days ago
| NPI Number | 1194715409 |
| Organization Name | NEW JERSEY VETERANS MEMORIAL HOME MENLO PARK |
| Address | 132 Evergreen Rd, Edison, NJ 08837 |
| Phone Number | 732-452-4167 |
News Archive
Children around the world are not moving enough to maintain healthy growth and development, according to a global report released today.
Oncologist and cancer care outcomes researcher Sharon H. Giordano, M.D., leads the new Department of Health Services Research at The University of Texas MD Anderson Cancer Center, a multidisciplinary area of research that examines the delivery, quality and costs of health care.
Half of the female population in the western world die of cardiovascular disease. Neither the women themselves, nor society at large recognizes this fact. Maybe because of this, research on women with acute coronary syndromes is scarce and thus we lack knowledge about the best way to properly treat women with an acute myocardial infarction.
A team led by Texas A&M University's College of Veterinary Medicine & Biomedical Sciences' researcher Dr. Stephen Safe has discovered a new pathway that may help suppress the development of glioblastoma tumors, one of the deadliest forms of cancer.
With the first U.S. implant of its new Activa SC neurostimulator for deep brain stimulation therapy, Medtronic, Inc. today announced the technology's commercial availability throughout the United States and Europe.
› Verified 7 days ago
| NPI Number | 1528239274 |
| Organization Name | STATE OF NEW JERSEY OMB CENTRALIZED PAYROLL |
| Doing Business As | NEW JERSEY VETERANS HOME AT MENLO PARK |
| Address | 132 Evergreen Rd, Edison, NJ 08837 |
| Phone Number | 732-452-4100 |
News Archive
Children around the world are not moving enough to maintain healthy growth and development, according to a global report released today.
Oncologist and cancer care outcomes researcher Sharon H. Giordano, M.D., leads the new Department of Health Services Research at The University of Texas MD Anderson Cancer Center, a multidisciplinary area of research that examines the delivery, quality and costs of health care.
Half of the female population in the western world die of cardiovascular disease. Neither the women themselves, nor society at large recognizes this fact. Maybe because of this, research on women with acute coronary syndromes is scarce and thus we lack knowledge about the best way to properly treat women with an acute myocardial infarction.
A team led by Texas A&M University's College of Veterinary Medicine & Biomedical Sciences' researcher Dr. Stephen Safe has discovered a new pathway that may help suppress the development of glioblastoma tumors, one of the deadliest forms of cancer.
With the first U.S. implant of its new Activa SC neurostimulator for deep brain stimulation therapy, Medtronic, Inc. today announced the technology's commercial availability throughout the United States and Europe.
› Verified 7 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Children around the world are not moving enough to maintain healthy growth and development, according to a global report released today.
Oncologist and cancer care outcomes researcher Sharon H. Giordano, M.D., leads the new Department of Health Services Research at The University of Texas MD Anderson Cancer Center, a multidisciplinary area of research that examines the delivery, quality and costs of health care.
Half of the female population in the western world die of cardiovascular disease. Neither the women themselves, nor society at large recognizes this fact. Maybe because of this, research on women with acute coronary syndromes is scarce and thus we lack knowledge about the best way to properly treat women with an acute myocardial infarction.
A team led by Texas A&M University's College of Veterinary Medicine & Biomedical Sciences' researcher Dr. Stephen Safe has discovered a new pathway that may help suppress the development of glioblastoma tumors, one of the deadliest forms of cancer.
With the first U.S. implant of its new Activa SC neurostimulator for deep brain stimulation therapy, Medtronic, Inc. today announced the technology's commercial availability throughout the United States and Europe.
› Verified 7 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 17.29 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 12.65 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 34.87 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.12 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0.98 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 1.12 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 99.88 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 15.18 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 98.57 | 83.88 |